Moli, Manilyn .
HRN: 27-79-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2025
CO-AMOXICLAV 625MG (TAB)
09/14/2025
09/21/2025
PO
1 Tab
Q8h
S/P NSVD
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines